Week In Review: Livzon Leads $26 Million Funding Of Cynvenio

Cynvenio is developing LiquidBiopsy, a technology that performs genomic analyses of circulating tumor cells from whole blood. Last month, Livzon said it invested $10m in Cynvenio with an additional $10m pledged for the future.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.